SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Portola Pharmaceuticals, Inc. Announces Upcoming Oral Presentation of Factor Xa Inhibitor Antidote Data at European Society of Cardiology 2011 Congress